Contineum Therapeutics, Inc. (CTNM) Free cash flow 2023–2025
Contineum Therapeutics, Inc. (CTNM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$55.5MFY2025 · since FY2023: $18.9M → -$55.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$55.5M | -66.5% |
| FY2024 | -$33.4M | -276.2% |
| FY2023 | $18.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice